Response to letter from Du et al. regarding article 'Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?'

Diabetes Obes Metab. 2023 Feb;25(2):630-633. doi: 10.1111/dom.14913. Epub 2022 Nov 15.
No abstract available

Keywords: GLP-1; SGLT2 inhibitor; cardiovascular disease; cohort study; type 2 diabetes.

Publication types

  • Letter
  • Comment

MeSH terms

  • Arrhythmias, Cardiac / chemically induced
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Heart Arrest* / chemically induced
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Stroke* / epidemiology
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose
  • Sodium